glp-1/fgf21 agonist boehringer A novel dual ZT003 has therapeutic potential for obesity, MASH and SHTG A novel GLP-1 and FGF21

Description

10.1007/s00223-009-9220-3 27 Nuche-BerenguerB.Portal-NezS.MorenoP.GonzlezN.AcitoresA.Lpez-HerradnA.et al (2010)

Orforglipron had a similar safety profile as other GLP-1 receptor agonists. Trial outcomes For ATTAIN-2, researchers enrolled 1,613 adults aged 18 years and older with obesity or overweight plus one weight-related comorbidity, and with type 2 diabetes with an HbA1c between 7% and 10% at baseline (mean age, 56.8 years

This phenomenon was observed in the famous Minnesota Starvation Diet, where men in WW2 concentration camps were starved and were noted to have intrusive food thoughts, among many other side effects

Surgical management of obesity among people with schizophrenia and bipolar disorder: a systematic review of outcomes and recommendations for future research